Currently, there are 128.19M common shares owned by the public and among those 75.85M shares have been available to trade.
The company’s stock has a 5-day price change of -12.82% and -16.58% over the past three months. SGRY shares are trading -3.97% year to date (YTD), with the 12-month market performance down to -19.71% lower. It has a 12-month low price of $19.50 and touched a high of $33.97 over the same period. SGRY has an average intraday trading volume of 993.03K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -11.40%, -9.17%, and -18.72% respectively.
Institutional ownership of Surgery Partners Inc (NASDAQ: SGRY) shares accounts for 71.25% of the company’s 128.19M shares outstanding.
It has a market capitalization of $2.61B and a beta (3y monthly) value of 1.94. The earnings-per-share (ttm) stands at -$1.53. Price movements for the stock have been influenced by the stock’s volatility, which stands at 6.69% over the week and 3.18% over the month.
Earnings per share for the fiscal year are expected to increase by 9.74%, and 19.55% over the next financial year. EPS should grow at an annualized rate of 13.35% over the next five years, compared to 10.25% over the past 5-year period.
Looking at the support for the SGRY, a number of firms have released research notes about the stock. BofA Securities stated their Buy rating for the stock in a research note on December 16, 2024, with the firm’s price target at $30. UBS coverage for the Surgery Partners Inc (SGRY) stock in a research note released on October 14, 2024 offered a Buy rating with a price target of $38. KeyBanc Capital Markets was of a view on October 11, 2024 that the stock is Sector Weight, while Macquarie gave the stock Outperform rating on June 28, 2024, issuing a price target of $31. Barclays on their part issued Equal Weight rating on March 06, 2024.
